142 related articles for article (PubMed ID: 11712682)
1. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
Farid P; Gomb SZ; Péter I; Szende B
Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions.
Letsas KP; Frangou-Lazaridis M; Skyrlas A; Tsatsoulis A; Malamou-Mitsi V
Pathol Int; 2005 Nov; 55(11):694-702. PubMed ID: 16271081
[TBL] [Abstract][Full Text] [Related]
4. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
5. Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
Pol J Pathol; 2004; 55(4):133-41. PubMed ID: 15757200
[TBL] [Abstract][Full Text] [Related]
6. Expression of apoptosis-related proteins in thyroid tumors and thyroid carcinoma cell lines.
Bröcker M; de Buhr I; Papageorgiou G; Schatz H; Derwahl M
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():20-3. PubMed ID: 8980994
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bax, Bcl-2, and P53 in progressive multifocal leukoencephalopathy.
Yang B; Prayson RA
Mod Pathol; 2000 Oct; 13(10):1115-20. PubMed ID: 11048806
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer.
Paradiso A; Simone G; Lena MD; Leone B; Vallejo C; Lacava J; Dellapasqua S; Daidone MG; Costa A
Br J Cancer; 2001 Mar; 84(5):651-8. PubMed ID: 11237386
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
Omar E; Madhavan M; Othman NH
Pathology; 2004 Apr; 36(2):152-9. PubMed ID: 15203751
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
12. Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.
Hsia JY; Chen CY; Hsu CP; Shai SE; Yang SS; Chuang CY; Wang PY; Chen JT
Neoplasma; 2001; 48(6):483-8. PubMed ID: 11949842
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma.
Kaseta MK; Khaldi L; Gomatos IP; Tzagarakis GP; Alevizos L; Leandros E; Papagelopoulos PJ; Soucacos PN
J Surg Oncol; 2008 Mar; 97(3):259-66. PubMed ID: 18161867
[TBL] [Abstract][Full Text] [Related]
15. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
Brambilla E; Gazzeri S; Lantuejoul S; Coll JL; Moro D; Negoescu A; Brambilla C
Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834
[TBL] [Abstract][Full Text] [Related]
16. Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid.
Nasir A; Catalano E; Calafati S; Cantor A; Kaiser HE; Coppola D
In Vivo; 2004; 18(2):189-95. PubMed ID: 15113046
[TBL] [Abstract][Full Text] [Related]
17. BCL2 and BAX expression in hyperplastic and dysplastic rectal polyps.
Giarnieri E; Nagar C; Valli C; Brunetti E; Palmieri MB; Vecchione A
Hepatogastroenterology; 2000; 47(31):159-62. PubMed ID: 10690601
[TBL] [Abstract][Full Text] [Related]
18. The potential role of BAX and BCL-2 expression in diffuse alveolar damage.
Guinee D; Brambilla E; Fleming M; Hayashi T; Rahn M; Koss M; Ferrans V; Travis W
Am J Pathol; 1997 Oct; 151(4):999-1007. PubMed ID: 9327733
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Bax, Bcl-2 and P53 in the HeLa apoptosis induced by co-immobilized cytokines].
Guan Y; Qiu L; Wang W
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):138-43. PubMed ID: 19334572
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]